Business Context and Reporting Period
Company: Harvard Bioscience, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: November 1, 2018
Reporting Period: Event date of November 1, 2018 (Amendment effective October 25, 2018).
This filing reports the entry into a material definitive agreement by Data Sciences International, Inc. (DSI), a wholly-owned subsidiary of Harvard Bioscience, Inc.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on a lease agreement amendment.
Material Changes
On November 1, 2018, DSI entered into Amendment No. 3 to its Lease Agreement with AX US L.P. for its headquarters in New Brighton, Minnesota. Key changes include:
- Lease Term Extension: The new term commences on July 1, 2020, and ends on September 30, 2030.
- Space Reduction: The amendment provides for a reduction in the leased space.
- Rent Adjustment: Base rent has been adjusted in relation to the reduced space.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, or outlook. No specific risks or contingencies are detailed beyond the standard incorporation of the lease amendment by reference.
Investor Verification Checklist
- Review Exhibit 10.1 (Third Amendment to Lease Agreement) for specific details on the rent adjustment amount and the exact square footage reduction.
- Verify the impact of the lease term extension (2020–2030) on future operating commitments.
- Confirm whether the space reduction aligns with the company's strategic operational plans for the DSI subsidiary.